Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 9 contracts
Samples: Securities Purchase Agreement (KALA BIO, Inc.), Securities Purchase Agreement (Bellicum Pharmaceuticals, Inc), Subscription Agreement (Proteostasis Therapeutics, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offeringoffering (or the earlier termination of this Agreement), the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) Sales or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 4 contracts
Samples: Subscription Agreement (ReShape Lifesciences Inc.), Subscription Agreement (ReShape Lifesciences Inc.), Merger Agreement (Reneo Pharmaceuticals, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) Sales or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 2 contracts
Samples: Stock Purchase Agreement (LENZ Therapeutics, Inc.), Subscription Agreement (Graphite Bio, Inc.)
Short Sales. Between the time the Purchaser Purchasers learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has Purchasers have not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has have the PurchaserPurchasers, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract
Samples: Securities Purchase Agreement (Idera Pharmaceuticals, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement from the Company, the Placement Agents or any other person and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person Person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract
Samples: Subscription Agreement (Protara Therapeutics, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) or similar transactions with respect to the Company’s Common Stock Stock, par value $0.001 per share (the “Common Stock”) or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Act (“Short Sales”)) Sales or similar transactions with respect to the Company Common Stock or any securities exchangeable or convertible for Company Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Company Common Stock.
Appears in 1 contract
Samples: Securities Purchase Agreement (Yumanity Therapeutics, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Exchange Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person Person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract
Samples: Stock Purchase Agreement (Cidara Therapeutics, Inc.)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Exchange Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract
Samples: Securities Purchase Agreement (Intercept Pharmaceuticals Inc)
Short Sales. Between the time the Purchaser learned about the offering contemplated by this Agreement and the public announcement of the offering, the The Purchaser has not engaged in any short sales (as defined in Rule 200 of Regulation SHO under the 1934 Exchange Act (“Short Sales”)) or similar transactions with respect to the Common Stock or any securities exchangeable or convertible for Common Stock, nor has the Purchaser, directly or indirectly, caused any person to engage in any Short Sales or similar transactions with respect to the Common Stock.
Appears in 1 contract